跳至主要内容
临床试验/ISRCTN74465643
ISRCTN74465643已完成未知

Reducing bilirubin-induced neurological dysfunction in preterm infants: additional use of the Bilirubin:Albumin Ratio in the treatment of hyperbilirubinemia

niversity Medical Centre Groningen (UMCG) (The Netherlands)0 个研究点目标入组 614 人开始时间: 2007年4月11日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
614

研究概览

简要总结

Meeting abstracts: 1. van Imhoff, DE; Dijk, PH; Bos, AF, et al. (2007) Dutch thresholds for unconjugated hyperbilirubinemia in preterm infants: when should treatment be started? ACTA PAEDIATRICA 96: 197-197 2. V W van den Belt, M van der Heide, D E van Imhoff, A F Bos, P H Dijk, C V Hulzebos, and Bart Studygroup (2008) IRRADIANCE LEVELS OF PHOTOTHERAPY IN JAUNDICED PRETERM INFANTS. Arch. Dis. Child. 93: p252 2008 results in: http://www.ncbi.nlm.nih.gov/pubmed/18450807 2013 hearing loss results in https://pubmed.ncbi.nlm.nih.gov/23667532/ (added 12/04/2021) 2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/24927259

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Preterm infants born at gestational age less than 32 weeks, either sex
  • 2. Admittance in the first 24 hours of life to a neonatal intensive care unit care centre in the Netherlands

排除标准

  • Major congenital malformations, clinical syndromes and chromosomal abnormalities that affect neurodevelopmental outcome

研究者

发起方
niversity Medical Centre Groningen (UMCG) (The Netherlands)

相似试验